News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
New Braeburn Pharma CEO Has Company on Track with Filing for Opioid Addiction Drug NDA     7/21/2017
Bay Area Nektar Therapeutics (NKTR)' Comeback is Stalled as the EMA Rejects Breast Cancer Drug     7/21/2017
Vertex (VRTX) Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials     7/20/2017
Ablynx (ABLYF) Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi (SNY)     7/20/2017
Roche (RHHBY) Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics     7/20/2017
Ironwood (IRWD)'s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial     7/20/2017
Kite Pharma (KITE) Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy     7/20/2017
FDA Green Lights Gilead (GILD)'s Vosevi, With a Black Box Warning Attached     7/20/2017
Samsung Bioepis Emerging as a Strong Player in the Autoimmune Space     7/20/2017
Another Alzheimer's Let-Down as FUJIFILM's Candidate Flunks Phase II Test     7/19/2017
Puma Biotech (PBYI) Surges After the FDA Officially Approves Breast Cancer Drug     7/19/2017
Safety Issues Force the FDA to Turn Down Amgen (AMGN), UCB SA's Osteoporosis Drug     7/18/2017
FDA Gives Nod to Johnson & Johnson (JNJ)'s Potential Blockbuster Psoriasis Med     7/17/2017
Novartis AG (NVS) Stocking Up on "Big-3" Arthritis Blockbusters to Get an Edge on Rivals     7/14/2017
FDA Panel Unanimously Endorses Novartis AG (NVS)'s CAR-T Leukemia Drug     7/14/2017

News from Around the Web
This Biotech Aims To Transform The Diagnosis Of Mental Illness. Michael Phelps Backs It. Can It Really Work?     7/21/2017
Startup Touts Neuro-Stimulation As 'Medicine For The Brain'     7/21/2017
A Treatment Option For Mccain: An Electric Cap That Kills Brain Cancer Cells     7/21/2017
Hemopurifier Filters Ebola, Hep C, Metastatic Melanoma: Interview With James A. Joyce, CEO Of Aethlon Medical (AEMD)     7/21/2017
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs     7/19/2017
Genentech (RHHBY) R&D Exec Reveals Alzheimer's is Still A Priority     7/19/2017
NanoVelcro Microchips Could Someday Noninvasively Diagnose Prenatal Conditions, ACS Nano Reveals     7/19/2017
Blood Test Identifies Key Alzheimer's Marker, Washington University School of Medicine Study Reveals     7/19/2017
Top 10 Therapeutic Areas In Biopharma R&D     7/18/2017
In Alzheimer's, The 'Juggernaut Is Changing Course,' Says TauRx Pharma Chief Exec     7/18/2017
Google (GOOG)'s Verily (GOOGL) Robots Just Released Millions Of Mosquitos In California     7/18/2017
New Device Detects Tumor Cells In Blood, Universitat Rovira i Virgili Study Reveals     7/18/2017
Breathable, Wearable Electronics On Skin For Long-Term Health Monitoring, University of Tokyo Study     7/18/2017
'Activity Inequality' Could Be One Of The Biggest Factors In Obesity, Stanford Study Reveals     7/17/2017

Press Releases
EU Regulators Give Nod to Advanced Accelerator Applications ' Med to Treat the Cancer That Killed Steve Jobs     7/21/2017
Syros Pharma Publishes Foundational Data Supporting Ongoing Phase II Clinical Trial Of SY-1425 For Genomically Defined AML And MDS Patients     7/21/2017
BioLogics Release: NERLYNX (Neratinib) Tablets Approved For HER2+ Breast Cancer In The Extended Adjuvant Setting     7/21/2017
Relypsa (RLYP) Announces European Approval Of Veltassa To Treat Adult Patients With Hyperkalemia (Elevated Blood Potassium Levels)     7/21/2017
Sunovion’s Latuda (Lurasidone HCI) Receives Health Canada Approval To Treat Adolescents With Schizophrenia     7/21/2017
Amgen (AMGN) Release: FDA Accepts Biologics License Application For Aimovig (erenumab)     7/21/2017
FDA Accepts Biologics License Application For AMG 334 (Erenumab), An Important Regulatory Milestone For Novartis AG (NVS)     7/21/2017
GlaxoSmithKline (GSK) Submits EU Filing For Extended Use Of Relvar Ellipta In Patients With Controlled Asthma On An ICS/LABA Combination     7/21/2017
Janssen-Cilag International NV (JNJ) Receives Positive CHMP Opinion For SYMTUZA The First Darunavir-Based Single-Tablet Regimen For The Treatment Of HIV     7/21/2017
Ipsen (IPN.PA) Receives Positive CHMP Opinion For Approval Of Xermelo (Telotristat Ethyl), For The Treatment Of Carcinoid Syndrome Diarrhea In Patients Inadequately Controlled By Somatostatin Analogue Therapy     7/21/2017
Merck KGaA (MKGAF.PK) Release: EMA's CHMP Issues Positive Opinion For Avelumab For The Treatment Of Metastatic Merkel Cell Carcinoma     7/21/2017
Vanda (VNDA) Receives Negative Opinion For Marketing Authorization From The EMA On Fanaptum For The Treatment Of Schizophrenia     7/21/2017
Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting From Dompe Research For The Treatment Of Moderate To Severe Neurotrophic Keratitis Is Made In Italy     7/21/2017
AbbVie (ABBV) Receives CHMP Positive Opinion For HUMIRA (Adalimumab) For The Treatment Of Pediatric Patients With Chronic Non-Infectious Anterior Uveitis     7/21/2017
EMA's CHMP Recommends Approval For Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer     7/21/2017

//-->